Developed in collaboration with leading academic healthcare institutions, Elekta's comprehensive VMAT solution, with 3D volumetric imaging and advanced treatment planning algorithms, allows more precise dose distribution and faster treatment delivery. Future developments include creating more efficacious and efficient approaches for clinicians to deliver patient care. For additional information, visit elekta.com/vmat.
*Monaco VMAT functionality is a works-in-progress.
About CMS Software
CMS Software is part of the Elekta Group, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated state of the art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to help in the cure of cancer patients with curable disease and to improve the quality of life of those patients with metastatic disease, making the future possible today.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
With more than 2,500 employees globally, Elekta's corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Exchange under the ticker EKTAb. More information can be found at
|SOURCE CMS Software|
Copyright©2009 PR Newswire.
All rights reserved